title: [Research progress on standards of commodity classes of Chinese materia medica and discussion on several key problems].
abstract: Standards of commodity classes of Chinese materia medica is an important way to solve the "Lemons Problem" of traditional Chinese medicine market. Standards of commodity classes are also helpful to rebuild market mechanisms for "high price for good quality". The previous edition of commodity classes standards of Chinese materia medica was made 30 years ago. It is no longer adapted to the market demand. This article researched progress on standards of commodity classes of Chinese materia medica. It considered that biological activity is a better choice than chemical constituents for standards of commodity classes of Chinese materia medica. It is also considered that the key point to set standards of commodity classes is finding the influencing factors between "good quality" and "bad quality". The article also discussed the range of commodity classes of Chinese materia medica, and how to coordinate standards of pharmacopoeia and commodity classes. According to different demands, diversiform standards can be used in commodity classes of Chinese materia medica, but efficacy is considered the most important index of commodity standard. Decoction pieces can be included in standards of commodity classes of Chinese materia medica. The authors also formulated the standards of commodity classes of Notoginseng Radix as an example, and hope this study can make a positive and promotion effect on traditional Chinese medicine market related research.
authors.forename: Guang
authors.initials: G
authors.lastname: Yang
authors.forename: Yan
authors.initials: Y
authors.lastname: Zeng
authors.forename: Lan-Ping
authors.initials: LP
authors.lastname: Guo
authors.forename: Lu-Qi
authors.initials: LQ
authors.lastname: Huang
authors.forename: Yan
authors.initials: Y
authors.lastname: Jin
authors.forename: Yu-Guang
authors.initials: YG
authors.lastname: Zheng
authors.forename: Yong-Yan
authors.initials: YY
authors.lastname: Wang
mesh_terms: D002681:China; D004345:Drug Industry / Q000191:economics / Q000592:standards*; D004365:Drugs, Chinese Herbal / Q000191:economics / Q000592:standards* / Q000627:therapeutic use; D006801:Humans; D008516:Medicine, Chinese Traditional / Q000191:economics / Q000379:methods / Q000592:standards*; D053723:Panax notoginseng / Q000033:anatomy & histology / Q000737:chemistry; D008517:Phytotherapy / Q000191:economics / Q000379:methods / Q000592:standards*; D018517:Plant Roots / Q000033:anatomy & histology / Q000737:chemistry; D011786:Quality Control; D012015:Reference Standards; D012106:Research / Q000639:trends
chemical_list: D004365:Drugs, Chinese Herbal